EMI - ETUDE MOULE INJECTION
EMI - ETUDE MOULE INJECTION is a leading company in the transformation of thermoplastic and composite materials, founded in 1995 in the tri-border region between France, Germany, and Switzerland. With its 360° Full Plastic Concept, the company offers comprehensive support to clients, starting from the study and development of parts, to the design and manufacturing of tools, and finally the injection or overmoulding of parts. EMI's dedication to research and development is evident in its 4.0 factory, positioning itself as a pioneer in thermoplastic injection and overmoulding of glass fiber-reinforced materials and hybrid injection of thermoplastic composites known as Organosheet.
EMI recently embarked on an extensive innovation project for Porsche, successfully combining strength, lightness, and functionality to compete with steel. The applications of Organosheet parts are widespread, particularly in automotive and aerospace structural components, as well as in the sports industry. With its commitment to excellence and innovative solutions, EMI aims to maintain its status as a quality reference in its industry.
In 2019, EMI achieved a turnover of 40 million euros, with 180 trilingual employees (French-German-English) and 75% of its production exported across various sectors including automotive, electrical, connectivity, renewable energy, construction, and medical.
While specific details regarding the headquarters, last investment, and investors are not available, EMI presents a compelling investment opportunity within the industrial and manufacturing sectors, given its innovative approach and strong financial performance.
There is no investment information
No recent news or press coverage available for EMI - ETUDE MOULE INJECTION.